Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Optimal thrombolysis].

T K Nordt, C Bode

    Zeitschrift Fur Kardiologie
    |September 22, 2001
    PubMed
    Summary
    This summary is machine-generated.

    New thrombolytic therapies for acute myocardial infarction offer equivalent efficacy and easier administration compared to alteplase. Combining reduced-dose thrombolytics with GP IIb/IIIa blockers and achieving normal myocardial microcirculation improves outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Usability and feasibility of E-nergEYEze: a blended vision-specific E-health based cognitive behavioral therapy and self-management intervention to reduce fatigue in adults with visual impairment.

    BMC health services research·2023
    Same author

    Preliminary Study on Open Labelled Randomized Controlled Trial of the Safety and Efficacy of Hydroxychloroquine and Chloroquine Phosphate for the Treatment of Persons Infected with 2019 Coronavirus Disease in Nigeria.

    West African journal of medicine·2023
    Same author

    The effectiveness of motivational interviewing on adherence to wearing orthopedic shoes in people with diabetes at low-to-high risk of foot ulceration: A multicenter cluster-randomized controlled trial.

    Diabetes research and clinical practice·2023
    Same author

    Attitudes and experiences towards the application of motivational interviewing by podiatrists working with people with diabetes at high-risk of developing foot ulcers: a mixed-methods study.

    Journal of foot and ankle research·2022
    Same author

    Using motivational interviewing combined with digital shoe-fitting to improve adherence to wearing orthopedic shoes in people with diabetes at risk of foot ulceration: study protocol for a cluster-randomized controlled trial.

    Trials·2021
    Same author

    Pro- and anti-inflammatory macrophages express a sub-type specific purinergic receptor profile.

    Purinergic signalling·2021
    Same journal

    [Not Available].

    Zeitschrift fur Kardiologie·2016
    Same journal

    [Not Available].

    Zeitschrift fur Kardiologie·2016
    Same journal

    [On pathogenesis of coronary heart disease].

    Zeitschrift fur Kardiologie·2016
    Same journal

    An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

    Zeitschrift fur Kardiologie·2016
    Same journal

    [Not Available].

    Zeitschrift fur Kardiologie·2016
    Same journal

    [Reconstructive surgery of the aortic root].

    Zeitschrift fur Kardiologie·2016
    See all related articles

    Area of Science:

    • Cardiology
    • Pharmacology
    • Emergency Medicine

    Background:

    • Thrombolytic therapy is a cornerstone treatment for acute myocardial infarction (AMI), improving long-term survival.
    • Advancements in thrombolytic agents aim to enhance efficacy and ease of administration.
    • Current strategies focus on optimizing reperfusion beyond epicardial artery patency.

    Purpose of the Study:

    • To evaluate the efficacy and administration of newer thrombolytic agents in AMI.
    • To explore combination therapies involving thrombolytics and GP IIb/IIIa blockers.
    • To assess the evolution of surrogate endpoints for optimal thrombolysis in AMI.

    Main Methods:

    • Comparison of third-generation thrombolytic agents (reteplase, lanoteplase, tenecteplase) against front-loaded alteplase.

    Related Experiment Videos

  • Analysis of clinical trials (TIMI-14, SPEED, INTRO-AMI) investigating combination strategies.
  • Evaluation of surrogate endpoints: coronary artery patency, TIMI-3 flow, and myocardial microcirculation.

    • Main Results:

    • Newer thrombolytic agents demonstrate mortality rates equivalent to alteplase.
    • Third-generation agents offer simpler administration via single or double bolus.
    • Combination therapy with reduced-dose thrombolytics and full-dose GP IIb/IIIa blockers shows promise.
    • Normal myocardial microcirculation is identified as a key factor for further mortality reduction.

    Conclusions:

    • Newer thrombolytic agents provide comparable efficacy and improved convenience for AMI treatment.
    • Optimizing thrombolysis involves a multi-faceted approach, including combination therapy and restoration of microvascular function.
    • Achieving normal myocardial microcirculation is crucial for maximizing survival benefits in AMI patients.